Journal for Managed Care & Specialty Pharmacy Issues Research Articles in July 2022 Edition

ALEXANDRIA, Virginia, June 24 -- The Journal for Managed Care and Specialty Pharmacy, a peer-reviewed journal that says it strives to engage and serve professionals in pharmacy, medicine, nursing and related fields to optimize the value of pharmaceutical products and pharmacy services delivered to patients from the Academy of Managed Care Pharmacy, published research articles on the following topics in its July 2022 edition:

Research:

* Analyzing the use and impact of elexacaftor/tezacaftor/ivacaftor on total cost of care and other health care resource utilization in a commercially insured population

* Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States

* Incidence and economic burden of respiratory syncytial virus among adults in the United States: A retrospective analysis using 2 insurance claims databases

* Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort

* Pharmacist-managed multistep order transmittal for electronic specialty prescriptions reduces represcribing burden in ambulatory clinics: A retrospective cohort pilot study

* Economic burden of interstitial lung disease in a commercially insured population with Sjogren syndrome in the United States

The July 2022 edition of the Journal for Managed Care & Specialty Pharmacy can be viewed at https://www.jmcp.org/toc/jmcsp/28/7.